Upstream Bio, Inc. Reports on Security Holder Vote
Ticker: UPB · Form: 8-K · Filed: Jun 12, 2025 · CIK: 2022626
| Field | Detail |
|---|---|
| Company | Upstream Bio, Inc. (UPB) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Upstream Bio held a shareholder vote on June 10th, details to follow.
AI Summary
Upstream Bio, Inc. filed an 8-K on June 12, 2025, reporting on a matter submitted to a vote of its security holders on June 10, 2025. The filing does not disclose the specific details of the vote or the outcome.
Why It Matters
This filing indicates a significant event involving shareholder decisions, which could impact the company's governance or strategic direction.
Risk Assessment
Risk Level: medium — The filing is a standard procedural report, but the lack of detail on the shareholder vote introduces some uncertainty.
Key Players & Entities
- Upstream Bio, Inc. (company) — Registrant
- June 10, 2025 (date) — Date of earliest event reported
- June 12, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Waltham, Massachusetts (location) — Principal executive offices
FAQ
What was the specific matter submitted to a vote of Upstream Bio, Inc.'s security holders on June 10, 2025?
The filing does not specify the exact matter that was submitted for a vote.
What was the outcome of the vote by Upstream Bio, Inc.'s security holders?
The filing does not disclose the results or outcome of the vote.
When did Upstream Bio, Inc. file this Current Report on Form 8-K?
Upstream Bio, Inc. filed this Current Report on Form 8-K on June 12, 2025.
What is the principal executive office address for Upstream Bio, Inc.?
The principal executive office address is 890 Winter Street, Suite 200, Waltham, Massachusetts 02451.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Upstream Bio, Inc. (UPB).